Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diagnostic Pathology
Published in: Diagnostic Pathology 1/2011

Open Access 01-12-2011 | Research

Invasive behavior of ulcerative colitis-associated carcinoma is related to reduced expression of CD44 extracellular domain: comparison with sporadic colon carcinoma

Authors: Tetuo Mikami, Tsutomu Yoshida, Yoshiko Numata, Masaomi Kikuchi, Kayo Araki, Norihiro Nakada, Isao Okayasu

Published in: Diagnostic Pathology | Issue 1/2011

Login to get access

Abstract

Background

To elucidate relations of invasion of ulcerative colitis (UC)-associated carcinoma with its prognosis, the characteristics of invasive fronts were analyzed in comparison with sporadic colonic carcinomas.

Methods

Prognoses of 15 cases of UC-associated colonic carcinoma were compared with those of sporadic colon carcinoma cases, after which 75 cases of sporadic invasive adenocarcinoma were collected. Tumor budding was examined histologically at invasive fronts using immunohistochemistry (IHC) of pancytokeratin. Expressions of beta-catenin with mutation analysis, CD44 extracellular domain, Zo-1, occludin, matrix matalloproteinase-7, laminin-5γ2, and sialyl Lewis X (LeX) were immunohistochemically evaluated.

Results

UC-associated carcinoma showed worse prognosis than sporadic colon carcinoma in all the cases, and exhibited a tendency to become more poorly differentiated when carcinoma invaded the submucosa or deeper layers than sporadic carcinoma. When the lesions were compared with sporadic carcinomas considering differentiation grade, reduced expression of CD44 extracellular domain in UC-associated carcinoma was apparent. Laminin-5γ2 and sialyl-LeX expression showed a lower tendency in UC-associated carcinomas than in their sporadic counterparts. There were no differences in the numbers of tumor budding foci between the two lesion types, with no apparent relation to nuclear beta-catenin levels in IHC.

Conclusions

UC-associated carcinoma showed poorer differentiation when the carcinoma invaded submucosa or deeper parts, which may influence the poorer prognosis. The invasive behavior of UC-associated carcinoma is more associated with CD44 cleavage than with basement membrane disruption or sialyl-Lewis-antigen alteration.
Appendix
Available only for authorised users
Literature
1.
Eaden JA, Abrams KR, Mayberry JF: The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001, 48 (4): 526-535. 10.1136/gut.48.4.526.PubMedCentralCrossRefPubMed
2.
Connell WA, Talbot IC, Harpaz N, Britto N, Wilkinson KH, Kamm MA, Lennard-Jones JE: Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut. 1994, 35 (10): 1419-1423. 10.1136/gut.35.10.1419.PubMedCentralCrossRefPubMed
3.
4.
Lavery IC, Chiulli RA, Jagelman DG, Fazio VW, Weakley FL: Survival with carcinoma arising in mucosal ulcerative colitis. Ann Surg. 1982, 195 (4): 508-512. 10.1097/00000658-198204000-00021.PubMedCentralCrossRefPubMed
5.
Mikami T, Mitomi H, Hara A, Yanagisawa N, Yoshida T, Tsuruta O, Okayasu I: Decreased expression of CD44, alpha-catenin, and deleted colon carcinoma and altered expression of beta-catenin in ulcerative colitis-associated dysplasia and carcinoma, as compared with sporadic colon neoplasms. Cancer. 2000, 89 (4): 733-740. 10.1002/1097-0142(20000815)89:4<733::AID-CNCR3>3.0.CO;2-#.CrossRefPubMed
6.
Jass JR, Baker M, Fraser L, Walsh MD, Whitehall VL, Babrielli B, Young J, Leggett BA: APC mutation and tumour budding in colorectal cancer. J Clin Pathol. 2003, 56 (1): 69-73. 10.1136/jcp.56.1.69.PubMedCentralCrossRefPubMed
7.
Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC: Tumour "budding" as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology. 2002, 40 (2): 127-132. 10.1046/j.1365-2559.2002.01324.x.CrossRefPubMed
8.
Ogawa T, Yoshida T, Tsuruta T, Tokuyama W, Adachi S, Kikuchi M, Mikami T, Saigenji K, Okayasu I: Tumor budding is predictive of lymphatic involvement and lymph node metastasis in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growth. Scand J Gastroenterol. 2009, 44 (5): 605-614. 10.1080/00365520902718911.CrossRefPubMed
9.
Ueno H, Mochizuki H, Hashiguchi Y, Shimazaki H, Aida S, Hase K, Matsukuma S, Kanai T, Kuruhara H, Ozawa K, Yoshimura K, Bekku S: Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 2004, 127 (2): 385-394. 10.1053/j.gastro.2004.04.022.CrossRefPubMed
10.
Gao AC, Lou W, Dong JT, Isaacs JT: CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res. 1997, 57 (5): 846-849.PubMed
11.
Takamune Y, Ikebe T, Nagano O, Nakayama H, Ota K, Obayashi T, Saya H, Shinohara M: ADAM-17 associated with CD44 cleavage and metastasis in oral squamous cell carcinoma. Virchows Arch. 2007, 450 (2): 169-177. 10.1007/s00428-006-0350-y.CrossRefPubMed
12.
Okamoto I, Tsuiki H, Kenyon LC, Godwin AK, Emlet DR, Hogado-Madruga M, Lanham IS, Joynes CJ, Vo KT, Guha A, Matsumoto M, Ushio Y, Saya H, Wong AJ: Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. Am J Pathol. 2002, 160 (2): 441-447. 10.1016/S0002-9440(10)64863-8.PubMedCentralCrossRefPubMed
13.
Kimura Y, Shiozaki H, Hirao M, Maeno Y, Doki Y, Inoue M, Monden T, Ando-Akatsuka Y, Furuse M, Tsukita S, Monden M: Expression of occludin, tight-junction-associated protein, in human digestive tract. Am J Pathol. 1997, 151 (1): 45-54.PubMedCentralPubMed
14.
Cadigan KM, Liu YI: Wnt signaling: complexity at the surface. J Cell Science. 2006, 119 (Pt3): 395-402. 10.1242/jcs.02826.CrossRefPubMed
15.
Doucas H, Garcea G, Neal CP, Manson MM, Berry DP: Changes in the Wnt signaling pathway in gastrointestinal cancers and their prognostic significance. Eur J Cancer. 2005, 41 (3): 365-379. 10.1016/j.ejca.2004.11.005.CrossRefPubMed
16.
Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y: Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med. 2006, 231 (1): 20-27.
17.
Remy L, Trespeuch C, Bachy S, Scoazec JY, Rouselle P: Matrilysin 1 influences colon carcinoma cell migration by cleavage of the laminin-5 beta3 chain. Cancer Res. 2006, 66 (23): 11228-11237. 10.1158/0008-5472.CAN-06-1187.CrossRefPubMed
18.
Pirilä E, Sharabi A, Salo T, Quaranta V, Tu H, Heljasvaara R, Koshikawa N, Sorsa T, Maisi P: Matrix metalloproteinases process the laminin-5γ2-chain and regulate epithelial cell migration. Biochem Biophys Res Commun. 2003, 303 (4): 1012-1017.CrossRefPubMed
19.
Irimura T, Matsushita Y, Hoff SD, Yamori T, Nakamori S, Frazier ML, Giacco GG, Cleary KR, Ota DM: Ectopic expression of mucins in colorectal cancer metastasis. Semin Cancer Biol. 1991, 2 (2): 129-139.PubMed
20.
Matsushita Y, Cleary KR, Ota DM, Hoff SD, Irimura T: Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastasis. Lab Invest. 1990, 63 (6): 780-791.PubMed
21.
Izawa M, Kumamoto K, Mitusoka C, Kanamori A, Ohmori K, Ishida H, Nakamura S, Kurata-Miura K, Sasaki K, Nishi T, Kannagi R: Expression of sialyl 6-sulfo Lewis × is inversely correlated with conventional sialyl Lewis × expression in human colorectal cancer. Cancer Res. 2000, 60 (5): 1410-1416.PubMed
22.
Izumi Y, Taniuchi Y, Tsuji T, Smith CW, Nakamori S, Fidler IJ, Irimura T: Characterization of human colon carcinoma variant cells selected for sialyl LeX carbohydrate antigen: liver colonization and adhesion to vascular endothelial cells. Exp Cell Res. 1995, 216 (1): 215-221. 10.1006/excr.1995.1027.CrossRefPubMed
23.
Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, Kabuto T, Iwanaga T, Matsushita Y, Irimura T: Increased expression of sialyl LewisX antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res. 1993, 53 (15): 3632-3637.PubMed
24.
Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, Izumi Y, Irimura T: Involvement of carbohydrate antigen sialyl LewisX in colorectal cancer metastasis. Dis Colon Rectum. 1997, 40 (4): 420-431. 10.1007/BF02258386.CrossRefPubMed
25.
Riddell RH, Goldman H, Ranshoff DF, Appelman HD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SR, Morson BC, Sommers SC, Yardley JH: Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical application. Hum Pathol. 1983, 14 (11): 931-968. 10.1016/S0046-8177(83)80175-0.CrossRefPubMed
26.
Hamilton SR, Aaltonen LA: World Health Organization. Classification of Tumours: Pathology and Genetics of Tumours of the Digestive System. 2001, Lyon, International Agency for Research on Cancer (IARC) Publications
27.
Sinicrope FA, Ruan SB, Clearly KR, Stephens LC, Lee JJ, Levin B: bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 1995, 55 (2): 237-241.PubMed
28.
Feng Han Q, Zhao W, Bentel J, Shearwood AM, Zeps N, Joseph D, Iacopetta B, Dharmarajan A: Expression of sFRP-4 and beta-catenin in human colorectal carcinoma. Cancer Lett. 2006, 231 (1): 129-137. 10.1016/j.canlet.2005.01.026.CrossRefPubMed
29.
Saegusa M, Hashimura M, Yoshida T, Okayasu I: Beta-catenin mutations and aberrant nuclear expression during endometrial tumorigenesis. Br J Cancer. 2001, 84 (2): 209-217. 10.1054/bjoc.2000.1581.PubMedCentralCrossRefPubMed
30.
Garinis GA, Spanakis NE, Menounos PG, Manolis EN, Peros G: Transcriptional impairment of beta-catenin/E-cadherin complex is not associated with beta-catenin mutations in colorectal carcinomas. Br J Cancer. 2003, 88 (2): 206-209. 10.1038/sj.bjc.6600706.PubMedCentralCrossRefPubMed
31.
Mirabelli-Primdahl L, Gryfe R, Kim H, Millar A, Luceri C, Dale D, Holowaty E, Bapat B, Gallinger S, Redston M: Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res. 1999, 59 (14): 3346-3351.PubMed
32.
Aust DE, Terdiman JP, Willenbucher RF, Chang CG, Molinaro-Clark A, Baretton GB, Loehrs U, Waldman FM: The APC/beta-catenin pathway in ulcerative colitis-associated colorectal carcinomas. Cancer. 2002, 94 (5): 1421-1427. 10.1002/cncr.10334.CrossRefPubMed
33.
Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, Seiki M: Membrane type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol. 2001, 153 (5): 893-904. 10.1083/jcb.153.5.893.PubMedCentralCrossRefPubMed
34.
Okamoto I, Kawano Y, Tsuiki H, Sasaki J, Nakao M, Matsumoto M, Suga M, Ando M, Nakajima M, Saya H: CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene. 1999, 18 (7): 1435-1446. 10.1038/sj.onc.1202447.CrossRefPubMed
35.
Matsumoto T, Iwao Y, Igarashi M, Watanabe K, Otsuka K, Watanabe T, Iizuka B, Hida N, Sada M, Chiba T, Kudo S, Oshitani N, Nagawa H, Ajioka Y, Hibi T: Endoscopic and chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis. Inflamm Bowel Dis. 2008, 14 (2): 259-264. 10.1002/ibd.20267.CrossRefPubMed
36.
Sada M, Igarashi M, Yoshizawa S, Kobayashi K, Katsumata T, Saigenji K, Otani Y, Okayasu I, Mitomi H: Dye spraying and magnifying endoscopy for dysplasia and cancer surveillance in ulcerative colitis. Dis Colon Rectum. 2004, 47 (11): 1816-1823. 10.1007/s10350-004-0682-0.CrossRefPubMed
Metadata
Title
Invasive behavior of ulcerative colitis-associated carcinoma is related to reduced expression of CD44 extracellular domain: comparison with sporadic colon carcinoma
Authors
Tetuo Mikami
Tsutomu Yoshida
Yoshiko Numata
Masaomi Kikuchi
Kayo Araki
Norihiro Nakada
Isao Okayasu
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2011
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-6-30

Other articles of this Issue 1/2011

Diagnostic Pathology 1/2011 Go to the issue

Case Report

Multifocal gastric gastrointestinal stromal tumors (GISTs) with lymph node metastases in children and young adults: A comparative clinical and histomorphological study of three cases including a new case of Carney triad

Research

Ultrasonography of simple intratesticular cysts: a 13 year experience in a single centre

Research

X-linked inhibitor of apoptosis positive nuclear labeling: a new independent prognostic biomarker of breast invasive ductal carcinoma

Research

Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China

Research

Technical note on the validation of a semi-automated image analysis software application for estrogen and progesterone receptor detection in breast cancer

Research

Adult urinary bladder tumors with rabdomyosarcomatous differentiation: Clinical, pathological and immunohistochemical studies